Literature DB >> 21220537

Antimicrobial resistance in more than 100,000 Escherichia coli isolates according to culture site and patient age, gender, and location.

José Miguel Sahuquillo-Arce1, María Selva, Hèctor Perpiñán, Miguel Gobernado, Carmen Armero, Antonio López-Quílez, Francisco González, Hermelinda Vanaclocha.   

Abstract

Escherichia coli and the antimicrobial pressure exerted on this microorganism can be modulated by factors dependent on the host. In this paper, we describe the distribution of antimicrobial resistance to amikacin, tobramycin, ampicillin, amoxicillin clavulanate, cefuroxime, cefoxitin, cefotaxime, imipenem, ciprofloxacin, fosfomycin, nitrofurantoin, and trimetoprim-sulfametoxazole in more than 100,000 E. coli isolates according to culture site and patient age, gender, and location. Bayesian inference was planned in all statistical analysis, and Markov chain Monte Carlo simulation was employed to estimate the model parameters. Our findings show the existence of a marked difference in the susceptibility to several antimicrobial agents depending on from where E. coli was isolated, with higher levels of resistance in isolates from medical devices, the respiratory system, and the skin and soft tissues; a higher resistance percentage in men than in women; and the existence of a clear difference in antimicrobial resistance with an age influence that cannot be explained merely by means of an increase of resistance after exposure to antimicrobials. Both men and women show increases in resistance with age, but while women show constant levels of resistance or slight increases during childbearing age and greater increases in the premenopausal age, men show a marked increase in resistance in the pubertal age. In conclusion, an overwhelming amount of data reveals the great adaptation capacity of E. coli and its close interaction with the host. Sex, age, and the origin of infection are determining factors with the ability to modulate antimicrobial resistances.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21220537      PMCID: PMC3067086          DOI: 10.1128/AAC.00765-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

1.  Antibiotic resistance rates and phenotypes among isolates of Enterobacteriaceae in French extra-hospital practice.

Authors:  C Quentin; C Arpin; V Dubois; C André; I Lagrange; I Fischer; J-P Brochet; F Grobost; J Jullin; B Dutilh; G Larribet; P Noury
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-19       Impact factor: 3.267

2.  [The importance of microbiological surveillance networks in monitoring resistant bacteria. RedMIVA].

Authors:  I Muñoz; H Vanaclocha; F González
Journal:  Rev Esp Quimioter       Date:  2007-06       Impact factor: 1.553

3.  Impact of biofilm matrix components on interaction of commensal Escherichia coli with the gastrointestinal cell line HT-29.

Authors:  X Wang; M Rochon; A Lamprokostopoulou; H Lünsdorf; M Nimtz; U Römling
Journal:  Cell Mol Life Sci       Date:  2006-10       Impact factor: 9.261

4.  Single-dose fosfomycin trometamol versus 5-day cephalexin regimen for treatment of uncomplicated lower urinary tract infections in women.

Authors:  G Elhanan; H Tabenkin; R Yahalom; R Raz
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

5.  Large-scale population structure of human commensal Escherichia coli isolates.

Authors:  Patricia Escobar-Páramo; Karine Grenet; Arnaud Le Menac'h; Luc Rode; Emmanuelle Salgado; Christine Amorin; Stéphanie Gouriou; Bertrand Picard; Mohamed Chérif Rahimy; Antoine Andremont; Erick Denamur; Raymond Ruimy
Journal:  Appl Environ Microbiol       Date:  2004-09       Impact factor: 4.792

6.  Differential effects of epinephrine, norepinephrine, and indole on Escherichia coli O157:H7 chemotaxis, colonization, and gene expression.

Authors:  Tarun Bansal; Derek Englert; Jintae Lee; Manjunath Hegde; Thomas K Wood; Arul Jayaraman
Journal:  Infect Immun       Date:  2007-06-25       Impact factor: 3.441

7.  Escherichia coli phylogenetic groups are associated with site of infection and level of antibiotic resistance in community-acquired bacteraemia: a 10 year population-based study in Denmark.

Authors:  Annette S Bukh; Henrik C Schønheyder; Jeppe M G Emmersen; Mette Søgaard; Søren Bastholm; Peter Roslev
Journal:  J Antimicrob Chemother       Date:  2009-05-08       Impact factor: 5.790

8.  Effect of androgens and glucocorticoids on microbial growth and antimicrobial susceptibility.

Authors:  Balbina J Plotkin; Robert J Roose; Quenby Erikson; Susan M Viselli
Journal:  Curr Microbiol       Date:  2003-12       Impact factor: 2.188

9.  Prevalence and risk factors for selection of quinolone-resistant Escherichia coli strains in fecal flora of patients receiving quinolone therapy.

Authors:  D Yagci; F Yoruk; A Azap; O Memikoglu
Journal:  Antimicrob Agents Chemother       Date:  2008-12-08       Impact factor: 5.191

10.  Ciprofloxacin-resistant Escherichia coli from bacteraemias in England; increasingly prevalent and mostly from men.

Authors:  David M Livermore; Tom Nichols; Theresa L Lamagni; Nicola Potz; Rosy Reynolds; Georgia Duckworth
Journal:  J Antimicrob Chemother       Date:  2003-10-29       Impact factor: 5.790

View more
  10 in total

Review 1.  The role of fluoroquinolones in the management of urinary tract infections in areas with high rates of fluoroquinolone-resistant uropathogens.

Authors:  Y-H Chen; W-C Ko; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-04       Impact factor: 3.267

2.  Increased multi-drug resistant Escherichia coli from hospitals in Khartoum state, Sudan.

Authors:  M E Ibrahim; N E Bilal; M E Hamid
Journal:  Afr Health Sci       Date:  2012-09       Impact factor: 0.927

3.  Antibiotic resistance among Escherichia coli isolates from stool samples of children aged 3 to 14 years from Ujjain, India.

Authors:  Pragya Shakya; Peter Barrett; Vishal Diwan; Yogyata Marothi; Harshada Shah; Neeraj Chhari; Ashok J Tamhankar; Ashish Pathak; Cecilia Stålsby Lundborg
Journal:  BMC Infect Dis       Date:  2013-10-14       Impact factor: 3.090

4.  Comparison of phenotypic characteristics and antimicrobial resistance patterns of clinical Escherichia coli collected from two unrelated geographical areas.

Authors:  Mutasim E Ibrahim; Naser E Bilal; Mohamed E Hamid
Journal:  Glob J Health Sci       Date:  2014-07-15

5.  Susceptibility of Austrian Clinical Klebsiella and Enterobacter Isolates Linked to Patient-Related Data.

Authors:  Alexandra Badura; Gudrun Pregartner; Judith C Holzer; Gebhard Feierl; Andrea J Grisold
Journal:  Front Microbiol       Date:  2016-02-05       Impact factor: 5.640

6.  Antibiotic Resistance in Urinary Isolates of Escherichia coli.

Authors:  Amila Abduzaimovic; Mufida Aljicevic; Velma Rebic; Sabina Mahmutovic Vranic; Kadrija Abduzaimovic; Sabina Sestic
Journal:  Mater Sociomed       Date:  2016-12

7.  Antibiotic Resistance, Virulence Factors, Phenotyping, and Genotyping of E. coli Isolated from the Feces of Healthy Subjects.

Authors:  Stefano Raimondi; Lucia Righini; Francesco Candeliere; Eliana Musmeci; Francesca Bonvicini; Giovanna Gentilomi; Marjanca Starčič Erjavec; Alberto Amaretti; Maddalena Rossi
Journal:  Microorganisms       Date:  2019-08-10

8.  Mid-term follow-up results after implementing a new strategy for the diagnosis and management of periprosthetic joint infections.

Authors:  Rares Mircea Birlutiu; Manuela Mihalache; Patricia Mihalache; Razvan Silviu Cismasiu; Victoria Birlutiu
Journal:  BMC Infect Dis       Date:  2021-08-12       Impact factor: 3.090

9.  Trends and impact of antimicrobial resistance on older inpatients with urinary tract infections (UTIs): A national retrospective observational study.

Authors:  Hoa Q Nguyen; Nga T Q Nguyen; Carmel M Hughes; Ciaran O'Neill
Journal:  PLoS One       Date:  2019-10-03       Impact factor: 3.240

10.  Major discrepancy between factual antibiotic resistance and consumption in South of France: analysis of 539,037 bacterial strains.

Authors:  Ousmane Oumou Diallo; Sophie Alexandra Baron; Gregory Dubourg; Hervé Chaudet; Philippe Halfon; Sabine Camiade; Béatrice Comte; Stéphanie Joubert; Arnaud François; Philippe Seyral; François Parisot; Jean-Paul Casalta; Raymond Ruimy; Christophe Maruejouls; Jean-Christophe Achiardy; Sophie Burignat; Joseph Carvajal; Edouard Delaunay; Sandra Meyer; Pierre-Yves Levy; Patricia Roussellier; Patrick Brunet; Claude Bosi; Philippe Stolidi; Jean-Pierre Arzouni; Gisele Gay; Pierre Hance; Philippe Colson; Didier Raoult; Jean-Marc Rolain
Journal:  Sci Rep       Date:  2020-10-26       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.